Responding to the Quest to Improve the Human Condition
New cell lines, heightened concerns about product safety, emerging biosimilars, and a vaccine industry shifting to cell culture–based production all point to a need for forward-thinking technology and product platforms. Leveraging core expertise in downstream chromatography purification, and rapid molecular-based contaminant testing, the biotherapeutics and vaccine production solutions from Applied Biosystems help solve everyday problems from improving capacity, resolution and yield to performing same-day critical impurity analyses. |
